Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting. - Wikidata - awgldk - TriplyDB

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

http://www.wikidata.org/entity/Q37258726

about

New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.Use of biologic agents in combination with other therapies for the treatment of psoriasis

P2860

Q26800937-2209FE6F-4CEC-42AC-A499-2CA1F22F1F91 Q33574671-10778136-D275-43F1-B9C9-484DA723DBA0 Q34553755-10137EFC-532B-4E2A-9E1F-FCC6FCDC91B6

P2860

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

http://www.wikidata.org/entity/Q37258726

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@en

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@nl

type

label

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@en

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@nl

prefLabel

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@en

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@nl

P1433

Q37258726-A6246F0A-0BEC-4DD7-BB56-677BCD72E6A8

P1476

Q37258726-59CA2B1D-8E21-4E18-B464-3DC336B463D9

P2093

Q37258726-0921BB18-BED9-4B24-99ED-1DF5F9171CD8

Q37258726-0B4CE1E6-9AE7-40F6-9963-24322E3C69CF

Q37258726-37B05E00-7B4F-4BFE-898F-C2F00C2540EA

Q37258726-44B83983-E51D-4AF5-9D98-8DB57008DE87

Q37258726-64B31F9F-98C8-4480-A3CB-6CD14B0B25D2

Q37258726-734E02C8-5B61-49E1-8702-D099CE6C870E

Q37258726-7F190DD8-F046-484F-AE15-06162F8FEF73

Q37258726-AF4CC033-0DEC-48BA-B375-3CF23005A63B

Q37258726-FD05A4A9-EF4F-4706-8CFD-D91C146A9CDB

P2860

Q37258726-00558EBD-9B9D-4C7D-80BF-7F0A1C4E9A1A

Q37258726-063A25E7-C806-4378-8924-22CCD7FC5FF5

Q37258726-06A89E0B-5434-48C6-8124-4EE9E0A5B3C3

Q37258726-0CF2B17D-E1FD-43A7-A777-3BB2A47D74DB

Q37258726-11F4E116-D628-46B6-98E2-819A077D9910

Q37258726-124C1E7E-5A9A-488E-B2DC-36F1B991C661

Q37258726-1DA901E8-4D18-46F2-A9EC-2EC7FFF15995

Q37258726-201E883B-87FC-42B7-8790-A89C0BBF510D

Q37258726-2D0B9E98-A598-48F4-8844-D1B53C708412

Q37258726-2D110124-5615-4739-A0BF-CC242848CE65

P304

Q37258726-53A3D041-B1D4-4E31-867A-18D853FB7565

P31

Q37258726-4432EE1E-D198-4DB7-9F9C-27D8A8F8A0BF

P433

Q37258726-0C846DFC-9D8A-42A0-BF85-CA1D0A7515DF

P478

Q37258726-A8B52A4E-E6A7-4BB8-814B-469D14A581D7

P577

Q37258726-888E1EBF-A5F2-46CE-92D9-E2CAAC38A33F

P698

Q37258726-DBB76680-1A32-448F-B2CA-B741DC787F46

P932

Q37258726-75DBBE80-0A60-43D4-962B-C6689EBF2B45

P1433

The Journal of clinical and aesthetic dermatology

P1476

Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2013 MauiDerm Meeting.

@en

P2093

Andrew Blauvelt

http://www.w3.org/2001/XMLSchema#string

Arthur Kavanaugh

http://www.w3.org/2001/XMLSchema#string

Bruce Strober

http://www.w3.org/2001/XMLSchema#string

Craig T Leonardi

http://www.w3.org/2001/XMLSchema#string

Eggert Stockfleth

http://www.w3.org/2001/XMLSchema#string

George Martin

http://www.w3.org/2001/XMLSchema#string

Kenneth B Gordon

http://www.w3.org/2001/XMLSchema#string

Marc Brown

http://www.w3.org/2001/XMLSchema#string

Neil A Swanson

http://www.w3.org/2001/XMLSchema#string

P2860

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

An update on the hyper-IgE syndromes

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for M

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options

Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Comorbidities associated with psoriasis - data from the malaysian psoriasis registry.

P304

S2-S20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

9 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24167640

http://www.w3.org/2001/XMLSchema#string

P932

3809592

http://www.w3.org/2001/XMLSchema#string